As First Citizens Bancshares (FCNCA) Share Value Rose, Holder Carroll Financial Associates Cut Position by $536,900; Dock Street Asset Management Position in Abbott Laboratories (ABT) Has Decreased by $703,339 as Shares Rose

August 12, 2018 - By Mark Babin

Abbott Laboratories (NYSE:ABT) Logo

Carroll Financial Associates Inc decreased its stake in First Citizens Bancshares Inc (FCNCA) by 17.81% based on its latest 2018Q1 regulatory filing with the SEC. Carroll Financial Associates Inc sold 1,300 shares as the company’s stock rose 3.07% while stock markets declined. The institutional investor held 6,000 shares of the finance company at the end of 2018Q1, valued at $2.48M, down from 7,300 at the end of the previous reported quarter. Carroll Financial Associates Inc who had been investing in First Citizens Bancshares Inc for a number of months, seems to be less bullish one the $5.26 billion market cap company. The stock increased 0.42% or $1.86 during the last trading session, reaching $441.61. About 38,355 shares traded. First Citizens BancShares, Inc. (NASDAQ:FCNCA) has risen 31.85% since August 12, 2017 and is uptrending. It has outperformed by 19.28% the S&P500.

Dock Street Asset Management Inc decreased its stake in Abbott Laboratories (ABT) by 29.63% based on its latest 2018Q1 regulatory filing with the SEC. Dock Street Asset Management Inc sold 11,921 shares as the company’s stock rose 3.04% while stock markets declined. The institutional investor held 28,309 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $1.70M, down from 40,230 at the end of the previous reported quarter. Dock Street Asset Management Inc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $112.33B market cap company. The stock decreased 0.94% or $0.61 during the last trading session, reaching $64.03. About 3.84 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 41.91% since August 12, 2017 and is uptrending. It has outperformed by 29.34% the S&P500. Some Historical ABT News: 18/05/2018 – ABBOTT: EXPLOSIVE DEVICES APPARENTLY WERE MADE BY THE SHOOTER; 23/05/2018 – ABBOTT CITES TENDYNE DEVICE FOR MITRAL VALVE REPLACEMENT; 22/05/2018 – FDA: ABBOTT RECALLS HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM; 18/04/2018 – Abbott Labs 1Q EPS 23c; 17/04/2018 – Investor Expectations to Drive Momentum within Bank of America, Abbott Laboratories, Analog Devices, Mohawk Industries, Maxwell; 18/05/2018 – ABBOTT: SUSPECT GOT GUNS FROM HIS FATHER, THE OWNER; 18/05/2018 – ABBOTT: SUSPECT MAY HAVE INTENDED TO COMMIT SUICIDE; 26/04/2018 – MEDIA-Abbott India stops importing Xience Alpine stents – Economic Times; 18/04/2018 – Abbott Labs 1Q Net $418M; 15/05/2018 – BSE Mumbai Bourse: Results from Abbott India for Jan 01 to Mar 31

More news for First Citizens BancShares, Inc. (NASDAQ:FCNCA) were recently published by: Globenewswire.com, which released: “First Citizens BancShares Declares Dividend” on July 26, 2018. Globenewswire.com‘s article titled: “First Citizens Bank, Palmetto Heritage Bancshares, Inc. Announce Merger Agreement” and published on July 25, 2018 is yet another important article.

Investors sentiment is 0.94 in 2018 Q1. Its the same as in 2017Q4. It is flat, as 6 investors sold FCNCA shares while 56 reduced holdings. only 27 funds opened positions while 31 raised stakes. 5.35 million shares or 0.74% less from 5.39 million shares in 2017Q4 were reported. Vanguard Inc invested 0.01% of its portfolio in First Citizens BancShares, Inc. (NASDAQ:FCNCA). River Road Asset Mgmt Ltd Co accumulated 14,904 shares. Citigroup has 0% invested in First Citizens BancShares, Inc. (NASDAQ:FCNCA) for 1,011 shares. Morgan Stanley stated it has 0% of its portfolio in First Citizens BancShares, Inc. (NASDAQ:FCNCA). Moreover, Zeke Advsr Ltd Llc has 0.02% invested in First Citizens BancShares, Inc. (NASDAQ:FCNCA). The Guernsey-based Bluecrest Mgmt has invested 0.01% in First Citizens BancShares, Inc. (NASDAQ:FCNCA). Panagora Asset Mgmt reported 40,945 shares stake. Geode Capital Mgmt Limited Liability Com invested 0.01% in First Citizens BancShares, Inc. (NASDAQ:FCNCA). Denali Limited Liability Corporation invested in 10 shares. Ajo Limited Partnership has invested 0.01% in First Citizens BancShares, Inc. (NASDAQ:FCNCA). 15,765 are held by Boston Advsr. Blackrock Incorporated owns 0.01% invested in First Citizens BancShares, Inc. (NASDAQ:FCNCA) for 507,977 shares. 517 were reported by Virtu Fincl Limited Liability Corp. Oppenheimer & holds 1,000 shares. Parametric Assocs Ltd Liability Corp has 11,852 shares for 0% of their portfolio.

Carroll Financial Associates Inc, which manages about $1.57 billion and $910.83M US Long portfolio, upped its stake in Schwab Fundamental U.S. Large Company Index Etf (FNDX) by 21,716 shares to 243,775 shares, valued at $8.86 million in 2018Q1, according to the filing. It also increased its holding in Powershares Ftse Rafi Us 1000 (PRF) by 44,933 shares in the quarter, for a total of 1.20M shares, and has risen its stake in Mckesson Corp (NYSE:MCK).

Since May 8, 2018, it had 11 insider purchases, and 0 sales for $904,764 activity. Shares for $378,000 were bought by HOLDING FRANK B JR on Tuesday, June 12. The insider Holding Olivia Britton bought $76,050. Another trade for 50 shares valued at $20,350 was made by DURHAM HAROLD LEE JR on Thursday, June 28. BRISTOW PETER M had bought 100 shares worth $38,500. Shares for $4,814 were bought by Hoppe Robert R. $38,500 worth of First Citizens BancShares, Inc. (NASDAQ:FCNCA) shares were bought by Bristow Claire H.

More news for Abbott Laboratories (NYSE:ABT) were recently published by: Seekingalpha.com, which released: “House repeals tax on medical devices” on July 25, 2018. Seekingalpha.com‘s article titled: “If AbbVie Is A Buy, What About Abbott?” and published on July 20, 2018 is yet another important article.

Since February 16, 2018, it had 1 buying transaction, and 21 selling transactions for $8.90 million activity. $16,369 worth of Abbott Laboratories (NYSE:ABT) shares were sold by Bracken Sharon J. $375,381 worth of stock was sold by Contreras Jaime on Wednesday, February 28. Shares for $17,609 were sold by Watkin Jared. The insider Fussell Stephen R sold 56,401 shares worth $3.36M. Another trade for 40,037 shares valued at $2.43M was made by STARKS DANIEL J on Tuesday, February 27. $183,592 worth of Abbott Laboratories (NYSE:ABT) was sold by Salvadori Daniel Gesua Sive.

Dock Street Asset Management Inc, which manages about $409.17M and $266.27M US Long portfolio, upped its stake in Nvidia (NASDAQ:NVDA) by 1,406 shares to 78,153 shares, valued at $18.10M in 2018Q1, according to the filing.

Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.08, from 0.91 in 2017Q4. It dived, as 44 investors sold ABT shares while 606 reduced holdings. 126 funds opened positions while 411 raised stakes. 1.22 billion shares or 0.54% more from 1.22 billion shares in 2017Q4 were reported. Palladium Prtn Lc has invested 0.25% of its portfolio in Abbott Laboratories (NYSE:ABT). 9,889 are held by Mar Vista Inv Ltd. Northeast Management has invested 0.72% of its portfolio in Abbott Laboratories (NYSE:ABT). United Services Automobile Association has 1.34 million shares for 0.22% of their portfolio. Aspiriant Limited Co has 34,606 shares. Moreover, Conestoga Advsr Limited Liability Corporation has 0.02% invested in Abbott Laboratories (NYSE:ABT). American Assets Investment Mngmt Lc holds 0.46% of its portfolio in Abbott Laboratories (NYSE:ABT) for 40,500 shares. Mcrae Cap Mgmt owns 8,954 shares for 0.24% of their portfolio. Coastline Tru invested in 0.25% or 27,317 shares. Graybill Bartz And Associate Limited reported 56,994 shares stake. Cap Inv Advisors Ltd Liability Co holds 8,910 shares or 0.03% of its portfolio. Riverhead Mngmt Limited Liability Corp accumulated 39,637 shares or 0.1% of the stock. Noesis Capital Mangement holds 0.08% or 3,596 shares. Texas Financial Bank Incorporated Tx has invested 0.78% in Abbott Laboratories (NYSE:ABT). Td Asset Mngmt has 1.51 million shares for 0.14% of their portfolio.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts